OCTOBER - 20206October - 23 - 2020, volume 04 - Issue 20 (ISSN 2691-4093) Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerChris LynnSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.com510.996.5123Contact usEmailPhone:510 230 0396 Fax:510-894-8405sales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com Copyright © 2020 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comMedical innovation has always been important for human development. Now, with breakthroughs in fields such as AI and 3D printing, medical researchers and entrepreneurs are making significant breakthroughs that allow for easy and more accurate diagnoses, improved treatments, drug discovery, customized prosthetics, and more. With the diversified APAC healthcare sector presenting myriad opportunities in every segment, including providers, payers and medical technology, the stage is set for further growth. In this scenario, a large number of MedTech startups are working on diagnostic solutions and preventive healthcare. Today, MedTech is becoming a priority area of medicine for states and a promising niche for private and venture capital. It is not only a profitable sector for the development of healthcare but also a necessary one. Nevertheless, MedTech remains a risky niche for investments, when it comes to projects that require lengthy R&D. Also, many projects, at some point, encounter legislative restrictions and cannot continue to exist. In essence, this risk also significantly affects the desire to invest in medicine.In this edition of MedTech Outlook, we bring you the story of some of the most successful MedTech startups in the Asia Pacific that delivers the best outcomes for their clients. This edition also offers a combination of thought leadership from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best MedTech Startup according to your requirements.Let us know your thoughts!Keeping an Eye on the New Players in the IndustrySarah FernandesEDITORIAL
< Page 5 | Page 7 >